Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2026-01-17 @ 2:14 PM
Study NCT ID:
NCT00655668
Status:
TERMINATED
Last Update Posted:
2019-11-25
First Post:
2008-04-04
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2010-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-04
First Submit QC Date:
None
Study First Post Date:
2008-04-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-11-30
Results First Submit QC Date:
None
Results First Post Date:
2012-01-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-14
Last Update Post Date:
2019-11-25
Last Update Post Date Type:
ACTUAL